1. Home
  2. CCLD vs RANI Comparison

CCLD vs RANI Comparison

Compare CCLD & RANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CareCloud Inc.

CCLD

CareCloud Inc.

HOLD

Current Price

$2.29

Market Cap

114.0M

Sector

Technology

ML Signal

HOLD

Logo Rani Therapeutics Holdings Inc.

RANI

Rani Therapeutics Holdings Inc.

HOLD

Current Price

$1.06

Market Cap

126.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCLD
RANI
Founded
1999
2012
Country
United States
United States
Employees
3650
N/A
Industry
Computer Software: Prepackaged Software
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
114.0M
126.8M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
CCLD
RANI
Price
$2.29
$1.06
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$7.50
AVG Volume (30 Days)
669.6K
874.2K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
57.14
EPS
N/A
N/A
Revenue
N/A
$1,633,000.00
Revenue This Year
$11.49
$274.77
Revenue Next Year
$7.95
$79.44
P/E Ratio
$32.04
N/A
Revenue Growth
N/A
58.85
52 Week Low
$1.98
$0.39
52 Week High
$4.01
$3.87

Technical Indicators

Market Signals
Indicator
CCLD
RANI
Relative Strength Index (RSI) 37.63 54.54
Support Level $2.22 $0.46
Resistance Level $3.14 $1.10
Average True Range (ATR) 0.16 0.09
MACD -0.00 0.01
Stochastic Oscillator 21.43 69.27

Price Performance

Historical Comparison
CCLD
RANI

About CCLD CareCloud Inc.

CareCloud Inc delivers flexible, tech-enabled solutions for healthcare providers of all sizes and multi-specialties across the U.S. It is a healthcare technology company offering cloud-based solutions that simplify clinical, administrative, and financial workflows for medical practices of all sizes. Its comprehensive suite includes Electronic Health Records (EHRs), Practice Management, Revenue Cycle Management (RCM), Medical Billing, Telehealth, and Patient Experience solutions. The group helps practices increase efficiency, improve patient care, and drive sustainable growth-all while ensuring HIPAA compliance and seamless integration. The operating segments of the group are Healthcare IT, which is the key revenue-generating segment, and Medical Practice Management.

About RANI Rani Therapeutics Holdings Inc.

Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.

Share on Social Networks: